Navigation Links
Regeneron Announces Receipt of Hart-Scott-Rodino Notice
Date:2/11/2013

TARRYTOWN, N.Y., Feb. 11, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)  today announced that it received from Sanofi a notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) that Sanofi intends to acquire Common Stock of Regeneron through open market purchases and direct purchases from shareholders.  As a result, Sanofi intends that the value of its ownership of voting securities of Regeneron stock will be in excess of the $500 million HSR Act notification threshhold. 

Pursuant to the Investor Agreement between Regeneron and Sanofi dated as of December 20, 2007, as amended, Sanofi is bound by certain "standstill" provisions including an agreement not to acquire more than 30% of the outstanding shares of Regeneron's class A stock and common stock.  Unless otherwise terminated pursuant to the Investor Agreement, these standstill provisions are in effect until the later of the fifth anniversaries of the expiration or earlier termination of the License and Collaboration Agreement, dated as of November 28, 2007, as amended, between Regeneron and Sanofi, and Regeneron's Collaboration Agreement dated as of September 5, 2003, as amended, with Aventis Pharmaceuticals Inc. (Sanofi's predecessor) for the development and commercialization of ZALTRAP® (ziv-aflibercept).

About Regeneron Pharmaceuticals, Inc.Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, rheumatoid arthritis, asthma, and atopic dermatitis.  For additional inform
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regeneron to Report Fourth Quarter and Full Year 2012 Financial and Operating Results and Host Conference Call and Webcast on February 14, 2013
2. Regeneron Announces Presentation at the Deutsche Bank 2012 dbAccess BioFEST
3. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
4. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
5. BioMed Realty Announces 80,500 Square Foot Lease Expansion For Regeneron Pharmaceuticals
6. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
7. Regeneron Announces September 2012 Investor Conference Presentations
8. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
9. Regeneron Announces June 2012 Investor Conference Presentations
10. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
11. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)...   Intarcia Therapeutics, Inc. today announced its ... Sessions of the American Diabetes Association taking place June ... the Boston Convention and Exhibition Center. The presentations span ... currently marketed and investigational therapies on patients with type ... late-stage clinical candidate, ITCA 650. , Saturday ...
(Date:6/3/2015)... , June 02, 2015 Research ... addition of the "2015 Strategies in the ... their offering. Highlights of the Report ... the US tumor marker testing market. , ... as well as key economic, regulatory, demographic, social ...
(Date:6/3/2015)... BARBARA, Calif. , June 3, 2015  The ... formal endorsement of a Midwife Kit as a standard ... Kit was developed by Direct Relief in consultation with ... of charge to midwives in developing countries. ... from complications related to their pregnancy or childbirth.  Skilled ...
Breaking Medicine Technology:Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 2Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 3Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 4United States Strategies in the Tumor Marker Testing Market 2015 2A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 2A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 3A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 4
(Date:6/3/2015)... Loma Linda University Health and Adventist Health ... Memorial Hospital (SGMH). The SGMH board voted unanimously to ... “Loma Linda University Health has been serving the Pass ... officer, Loma Linda University Medical Center. “We are thrilled ... this community.” , Under the proposed affiliation, Loma ...
(Date:6/3/2015)... NY (PRWEB) June 03, 2015 Johnson ... to pay $7.8 million to resolve a Risperdal lawsuit ... over tactics the company allegedly used to market the ... Circuit Court indicate that the Arkansas Attorney General moved ... of the accord. The Risperdal settlement amounts to just ...
(Date:6/3/2015)... 2015 The National Resident Matching Program ... C. Savoia, M.D., Dean of Medical Education at the University ... Chair on July 1. , “It is an ... Resident Matching Program,” said Dr. Savoia. “NRMP’s goal is ... medical students with training programs, and I welcome the opportunity ...
(Date:6/3/2015)... On the heels of a report predicting ... ( click here to review news coverage about the ... has the talent to become a world-leading center of ... other biological data are collected and analyzed to help scientists ... the elements of a perfect storm for bioinformatics leadership,” said ...
(Date:6/3/2015)... Jersey (PRWEB) June 03, 2015 Horizon Blue ... Diversity MBA Magazine as one of the nation’s top employers ... BCBSNJ No. 6 among its national list of Best Places ... BNCBSNJ as the No. 1 Regional Company. This is ... by Diversity MBA Magazine for its diverse workplace policies and ...
Breaking Medicine News(10 mins):Health News:Loma Linda University Health and Adventist Health Enter into Exclusive Affiliation Negotiations with San Gorgonio Memorial Hospital 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2
... Jan. 7 The following is a statement by ... of the State address put forth recommendations on a ... care and financial security of New Yorkers of all ... Family Health Plus Program to 200 percent of the ...
... Whether low levels would work for ER patients with ... -- Going to the world,s most elevated natural laboratory, ... medical rules about the amount of oxygen needed by ... people can tolerate extremely low levels of oxygen, much ...
... known as Emily,s Law, has received Governor Ted Strickland,s ... of Ohio. Named after Emily Jerry, Emily,s Law will ... law, which was originally sponsored by Senator Tim Grendell, ... Association. Emily,s Story , Emily Jerry died at ...
... Provide Support and Convenience CARLSBAD, Calif., Jan. 7 ... a new on-line service for physicians and patients ... products. The new Web site, www.skinmedica.com , ... while offering the convenience of on-line information and ...
... WESTCHESTER, Ill., Jan. 7 BrainLAB, Inc., ... medical treatments,announces a new, customer-focused sales and ... growth and an expanding product,portfolio. , ... and support structures, customers will benefit,from a ...
... AR, AZ, CO, FL, LA, NM and TXBOISE, Idaho, ... its Albertsons Rx-tra Savings prescription discount program ... a 90-day supply of over 500 generic drugs. ... its formulary of over 500 drugs that are already ...
Cached Medicine News:Health News:Study of Everest Climbers Questions Oxygen Use 2Health News:Study of Everest Climbers Questions Oxygen Use 3Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 3Health News:SkinMedica Launches On-Line Service for Physician Partners 2Health News:BrainLAB, Inc. Announces New, Streamlined Surgery Business Division 2Health News:Albertson's LLC Launches $10.99 for 90-day Supply of Generic Drugs as Part of Rx-tra Savings Prescription Discount Program 2
The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use....
... is the newest addition to the Primus ... the unbeatable combination of speed and accuracy ... or moderate volume testing. Test results in ... technology for the lab or clinic., ,The ...
... HbA1c Testing , Monoclonal antibody method ... , Correlation study shows 99% agreement with ... can count on a CV of ... National Glycohemoglobin Standardization Program (NGSP) certified method, ...
... M-4 is a manual hemostasis analyzer ... clotting assays - PTs, aPTTs, thrombins, ... easy, inexpensive, low-volume testing, this analyzer ... on features, offering time and labor ...
Medicine Products: